Prognostic significance of tissue DF3 antigen and CA15-3 tumor marker in primary breast cancer.
Cleanthi Dimas, M Fragos-Plemenos, C. Gennatas, E. Kouskouni, A Kondi-Paphitis
Abstract
Cleanthi Dimas, M Fragos-Plemenos, C. Gennatas, E. Kouskouni, A Kondi-Paphitis
Abstract
The specific monoclonal antibody, DF3, for breast cancer and the corresponding tumor marker CA15-3 were evaluated in 108 patients with primary cancer of the breast. These antigens correlated poorly with the known prognostic parameters. Elevated CA15-3 serum values were associated with the cytoplasmic distribution of the DF3 antigen in the cell. The DF3 distribution pattern and the CA15-3 serum values had prognostic significance for disease-free interval.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The specific monoclonal antibody, DF3, for breast cancer and the corresponding tumor marker CA15-3 were evaluated in 108 patients with primary cancer of the breast. These antigens correlated poorly with the known prognostic parameters. Elevated CA15-3 serum values were associated with the cytoplasmic distribution of the DF3 antigen in the cell. The DF3 distribution pattern and the CA15-3 serum values had prognostic significance for disease-free interval.
Key concepts: Medicine, CA15-3, Breast cancer, CA 15-3, Antigen, Monoclonal antibody, Cancer, Tumor marker